Poland has submitted an order for over 4 million doses of the EU's newly approved Novavax Covid vaccine, a Health Ministry spokesman said on Tuesday.
A new Covid vaccine and Molnupravir, an oral medicine for treating the disease, could be available in Poland in December, a senior medical official said on Tuesday.
Talks aimed at establishing Covid-19 vaccine production capabilities in Poland are ongoing between Polish authorities and companies, a pharmaceutical official has said.
Poland's plans to contain the coronavirus pandemic this year are viable, the CEO of the Polish branch of the US pharmaceutical company Pfizer has told PAP.
In this episode of The Debrief, we get the inside info from Mabion, a Polish biotech firm which has teamed up with Novavax in the US to produce Covid vaccines.
The prime minister has urged the European Commission and the European Medicines Agency to approve the Johnson&Johnson vaccine as soon as possible.
Biotech firm Mabion said it had signed a deal with the US company for the ‘transfer of technology and technological trials in the manufacture of an antigen for Novavax's Covid-19 vaccine’.
Poland plans to sign contracts with two new vaccines suppliers, Novavax and Johnson&Johnson, in the second quarter of this year, the health minister said on Monday.